Retinal vein occlusion is a leading cause of sudden vision loss. Learn the key risk factors like high blood pressure and diabetes, and how anti-VEGF and steroid injections help restore vision. Understand treatment realities, costs, and what’s coming next.
Medicare can now negotiate drug prices for the first time under the Inflation Reduction Act. Discover how this cuts costs for seniors, changes insurer discounts, and reshapes the entire U.S. drug pricing system.
Most people don't tell their doctors about dietary supplements-even though they can interact dangerously with medications. Learn why full disclosure matters, which supplements are riskiest, and how to talk to your care team safely.
Buyers like Medicare use the presence of generic drugs to negotiate lower prices for brand-name medications. Generic competition drives prices down by over 90% in many cases, making it a key tool for controlling drug costs.
Explore how genetics, therapeutic monitoring, and new delivery methods can personalize ethambutol therapy, reduce eye toxicity, and boost TB treatment success.
Explore how common performance‑enhancing drugs affect athletes' health, the key side effects, real‑world data, and safe alternatives for optimal performance.